المؤلفون: Alexander Hapfelmeier, Sebastian Foersch, Siranush Karapetyan, Daniel-Christoph Wagner, Katja Steiger, Kristina Schwamborn, Marion Kiechle, Wilko Weichert, Wilfried Roth, Dirk Oettler, Aurelia Noske

المصدر: Breast, Vol 60, Iss, Pp 238-244 (2021)
The Breast : Official Journal of the European Society of Mastology

مصطلحات موضوعية: Oncology, CPS, combined positive score, TC, tumor cells, ICI, immune checkpoint inhibitor, Triple Negative Breast Neoplasms, B7-H1 Antigen, Medicine, HER2, human epidermal growth factor receptor 2, Triple-negative breast cancer, RC254-282, ICC, intraclass correlation coefficient, biology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, MSI, microsatellite instability, Immunohistochemistry, pCR, pathological complete response, PFS, progression-free survival, Original Article, IC-Score, IC, immune cells, IHC, immunohistochemistry, Programmed death, PD-L1, medicine.medical_specialty, Concordance, TNBC, triple-negative breast cancer, OS, overall survival, Breast cancer, Internal medicine, TPS, tumor proportion score, Biomarkers, Tumor, Humans, Programmed death-ligand 1, Reproducibility, business.industry, Reproducibility of Results, medicine.disease, ITT, intention to treat, CI, confidence interval, PD-L1, programmed death-ligand 1, biology.protein, Surgery, CPS, business, Kappa, TMB, tumor mutational burden

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a50b5eac3f8c4ff158e8c3f6dfcb0cTest
http://www.sciencedirect.com/science/article/pii/S0960977621009851Test

المؤلفون: Eleonora De Maio, Gabrielle Selmes, Slimane Zerdoud, Eva Jouve, R. Aziza, Jean-Louis Lacaze, Ciprian Chira, F. Izar, Florence Dalenc, C. Massabeau, Mony Ung, Anne Pradines

المصدر: Breast, Vol 59, Iss, Pp 144-156 (2021)
The Breast : Official Journal of the European Society of Mastology

مصطلحات موضوعية: Oncology, Review, NA, not applicable, Circulating Tumor DNA, law.invention, Circulating tumor cell, Randomized controlled trial, law, Epidemiology, HER2, human epidermal growth factor receptor 2, ctDNA, circulating tumor DNA, RC254-282, Curative intent, Incidence (epidemiology), Incidence, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, CTCs, circulating tumor cells, Neoplastic Cells, Circulating, Observational Studies as Topic, CT scan, Computed Tomography scan, 18F-FDG-PET/CT, Positron Emission Tomography/Computed Tomography with 18fluorodeoxyglucose, Female, CTCs, Cohort study, medicine.medical_specialty, 18F-FES, 16α-[18F]-Fluoro- 17β-estradiol, Breast Neoplasms, MRI, Magnetic Resonance Imaging, OMD, oligometastatic disease, OS, overall survival, MBC, Metastatic Breast Cancer, Breast cancer, Internal medicine, RFS, relapse-free survival, Biomarkers, Tumor, medicine, Humans, OMBC, oligometastatic breast cancer, Oligometastatic breast cancer, Biology, business.industry, HR, hormone receptor, Definition, medicine.disease, WB-MRI, Whole-body MRI, MicroRNAs, NED, No Evidence of Disease, SBR grade, Scarf-Bloom-Richardson grade, SBRT, Stereotactic Body Radiotherapy, Surgery, Observational study, Observatory, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b69d7d75860baca5664d0f6f4d7d4a88Test
http://www.sciencedirect.com/science/article/pii/S0960977621004069Test

المؤلفون: Kyung Hwan Shin, Yong Bae Kim, Jinhyun Choi, Sei One Shin, Jung Ho Im, Chang Ok Suh, Yeon Joo Kim, Haeyoung Kim, Sea Won Lee, Dong Soo Lee, Jee Suk Chang, Seung Yeun Chung, Ik Jae Lee, Jihye Cha, Kyu Chan Lee, Won Sup Yoon, Boram Ha, Sun Young Lee, Jeongshim Lee, Sung Ja Ahn, Jinhee Kim, Mi Young Kim, Won Soon Park, Jin Hwa Choi, Kyubo Kim, Jin Ho Kim

المصدر: The Breast : Official Journal of the European Society of Mastology
Breast, Vol 56, Iss, Pp 7-13 (2021)

مصطلحات موضوعية: Adult, medicine.medical_specialty, Multivariate analysis, EQD2, equivalent dose in 2 Gy fractions, medicine.medical_treatment, Mammaplasty, Context (language use), Breast Neoplasms, Major complication, Radiation Dosage, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, PMRT, post-mastectomy radiotherapy, OD, odds ratio, Clinical endpoint, Medicine, Humans, Breast reconstruction, HER2, human epidermal growth factor receptor 2, 030212 general & internal medicine, Mastectomy, Aged, Retrospective Studies, RT, Radiotherapy, MROC, Mastectomy Reconstruction Outcomes Consortium, business.industry, General Medicine, Odds ratio, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Confidence interval, Radiation therapy, CI, confidence interval, Treatment Outcome, 030220 oncology & carcinogenesis, Surgery, Original Article, Female, Radiotherapy, Adjuvant, Radiology, Dose Fractionation, Radiation, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::961e1d4c717830d89e8ba42c835fe7deTest
http://europepmc.org/articles/PMC7848800Test

المؤلفون: Mami Ogita, Hideomi Yamashita, Kenji Tokumasu, Kenshiro Shiraishi, Jiro Kawamori, Naomi Nakajima, Katsuyuki Karasawa, Ta-Chen Chang, Keiichi Nakagawa

المصدر: Breast, Vol 52, Iss, Pp 88-94 (2020)
The Breast : official journal of the European Society of Mastology

مصطلحات موضوعية: Oncology, PMRT, post-mastectomy radiotherapy (PMRT), ER, estrogen receptor, Lymphovascular invasion, medicine.medical_treatment, SCC, squamous cell carcinoma, AC, doxorubicin and cyclophosphamide, Cohort Studies, 0302 clinical medicine, Breast cancer, Risk Factors, Recurrence, Squamous cell carcinoma, HER2, human epidermal growth factor receptor 2, 030212 general & internal medicine, Lymph node, Aged, 80 and over, CMF, cyclophosphamide, methotrexate, and 5-fluorouracil, BCSS, breast cancer-specific survival, Incidence (epidemiology), General Medicine, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.anatomical_structure, RFi, recurrence-free interval, 030220 oncology & carcinogenesis, Lymphatic Metastasis, FEC, epirubicin and cyclophosphamide, Carcinoma, Squamous Cell, Female, Original Article, IDC, invasive ductal carcinoma, Mastectomy, PARP, poly (ADP-ribose) polymerase, Adult, medicine.medical_specialty, FAP, 5-FU, cisplatin and doxorubicin, RNI, regional nodal irradiation, Breast Neoplasms, UICC, the Union for International Cancer Control, CTCAE, the Common Terminology Criteria for Adverse Events, lcsh:RC254-282, OS, overall survival, 03 medical and health sciences, Internal medicine, medicine, Humans, EBCTCG, the Early Breast Cancer Trialists’ Collaborative Group, Aged, Retrospective Studies, Radiotherapy, business.industry, Retrospective cohort study, medicine.disease, SEER, the Surveillance, Epidemiology and End Results, Survival Analysis, EGFR, epidermal growth factor receptor, Radiation therapy, PgR, progesterone receptor, Surgery, Radiotherapy, Adjuvant, Neoplasm Recurrence, Local, business, Rare disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83cd3dd2311652559da301e9ed118ed7Test
http://www.sciencedirect.com/science/article/pii/S0960977620301107Test

المؤلفون: Quchang Ouyang, Xin Yi, Xiaohong Yang, Jianxiang Gao, Zheyu Hu, Xuming Hu, Can Tian, Lianpeng Chang, Xuefeng Xia, Yu Tang, Qianjin Liao, Mengjia Xiao, Qiongzhi He, Liping Liu, Hui Wu, Jing Li, Jun Lu, Ning Xie, Huawu Xiao, Min Cao, Zhengrong Shui

المصدر: EBioMedicine
EBioMedicine, Vol 32, Iss, Pp 111-118 (2018)

مصطلحات موضوعية: 0301 basic medicine, Oncology, MBC, metastatic breast cancer, ER, estrogen receptor, Receptor, ErbB-2, Gene mutation pattern, Estrogen receptor, lcsh:Medicine, Drug resistance, SNV, Single nucleotide variants, Gene mutation, medicine.disease_cause, Circulating Tumor DNA, SEER, Surveillance Epidemiology and End Results, AUC, area under the curve, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, HER2, human epidermal growth factor receptor 2, ctDNA, circulating tumor DNA, Indels, insertions and deletions, Neoplasm Metastasis, skin and connective tissue diseases, Triple-negative breast cancer, TNBC, triple negative breast cancer, Mutation, lcsh:R5-920, Mediator Complex, BRCA1 Protein, Progression-free survival, General Medicine, Middle Aged, Metastatic breast cancer, PFS, progression-free survival, Drug Resistance, Multiple, Gene Expression Regulation, Neoplastic, GX, gemcitabine+capecitabine, 030220 oncology & carcinogenesis, Disease Progression, Female, lcsh:Medicine (General), Circulating tumor DNA (ctDNA), WES, whole exome sequencing, IHC, immunohistochemistry, Research Paper, Adult, medicine.medical_specialty, Class I Phosphatidylinositol 3-Kinases, Breast Neoplasms, General Biochemistry, Genetics and Molecular Biology, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Biomarkers, Tumor, Humans, neoplasms, AI, aromatase inhibitor, Aged, HR/HER2 subtype, TMB, Tumor mutation burden, business.industry, lcsh:R, Cancer, HR, hormone receptor, PR, progesterone receptor, cfDNA, cell-free DNA, medicine.disease, HR, hazard ratio, ROC, receiver operating characteristic, CI, confidence interval, 030104 developmental biology, Drug Resistance, Neoplasm, gDNA, genomic DNA, Tumor Suppressor Protein p53, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09ba2a916d616434f8644bf3d44cb54dTest
http://europepmc.org/articles/PMC6020712Test

المؤلفون: Paul Delmar, Lu Tian, Cornelia Irl

المصدر: Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 5, Iss C, Pp 107-115 (2017)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, RCT, randomized clinical trial, Bevacizumab, Placebo, 01 natural sciences, Article, law.invention, 010104 statistics & probability, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Randomized controlled trial, law, Internal medicine, Machine learning, medicine, MRST, in mean restricted survival time, HER2, human epidermal growth factor receptor 2, 0101 mathematics, Pharmacology, lcsh:R5-920, business.industry, Hazard ratio, General Medicine, medicine.disease, Metastatic breast cancer, Personalized medicine, VEGF, vascular endothelial growth factor, Confidence interval, 3. Good health, FGF, fibroblast growth factor, FLT, fms-like tyrosine kinase, 030220 oncology & carcinogenesis, Multiple comparisons problem, Population study, Subgroup analysis, Multivariate statistical classification, business, lcsh:Medicine (General), medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abf31ea1146afb07efdf89e7a5e517caTest
http://europepmc.org/articles/PMC5936698Test